Kentucky Overdose Deaths Plunge 23% in 2025, Marking Four Years of Decline
Kentucky reports lowest overdose death toll since 2014, with 1,101 fatalities representing 50% decrease from 2021 peak
May 11, 20265 min read
Blog & News
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
AllFederal PolicyOpioid CrisisTreatment AccessHarm ReductionClinical ResearchMedication-Assisted Treatmenttreatment-accessState LegislationOpioid AddictionSubstance Use DisorderMental HealthPsychedelicsFundingclinical-researchClinical Trialsopioid-crisisopioid-addictionsubstance-use-disordermedication-assisted-treatmentfederal-policyharm-reductiondata-reportsData Reportsstate-legislationmental-healthclinical-trialsAlcohol Addictionbehavioral-therapyfundingTelehealthBuprenorphineMedication Assisted Treatmentpsychedelicsbuprenorphinedigital-healthtelehealthSubstance-Use-DisorderDigital Healthalcohol-addictionSynthetic OpioidsFederal-PolicyClinical-TrialsClinical-ResearchLitigationInternationalStimulant AddictionTreatment OptionsRecoveryRehabilitationResearch
Opioid Overdose Survivors Face Triple the Risk of Repeat Overdoses, JAMA Study Finds
New research reveals 21% of opioid overdose survivors experience repeat overdoses within a year—far exceeding previous estimates—as fentanyl transforms the crisis landscape.
May 10, 20265 min read
Yale-Led Expert Panel Defines New Standards for Hospital-Based Opioid Addiction Treatment
Forty-two addiction specialists establish consensus best practices for initiating medications for opioid use disorder in hospitals, adapting protocols for the fentanyl era.
May 10, 20266 min read
NIH Study Reveals How New Weight-Loss Drugs Rewire Brain Circuits to Suppress Cravings
Research identifies novel mechanism where oral GLP-1 medications penetrate deep into brain's reward center, opening potential pathways for treating addiction
May 9, 20266 min read
Single Dose of Psilocybin Shows Promise for Cocaine Addiction in Landmark UAB Trial
JAMA study finds psychedelic-assisted therapy produced higher abstinence rates and longer relapse prevention than standard treatment
May 9, 20266 min read
Massachusetts Panel Urges Action on Xylazine and Emerging Drug Threats
State commission recommends expanding low-barrier treatment and harm reduction as xylazine gives way to medetomidine in the illicit drug supply.
May 8, 20265 min read
Tennessee Enacts HOPE Act, Clearing Path for Ibogaine Clinical Trials
Tennessee becomes latest state to legalize FDA-approved ibogaine research, joining Texas and Arizona in studying the psychedelic for PTSD and opioid addiction treatment.
May 8, 20265 min read
New Hampshire Secures $29.5 Million from Purdue Pharma Settlement to Combat Opioid Crisis
New Hampshire will receive $29.5 million over 10 years from the Purdue Pharma settlement to fund prevention, treatment, and recovery programs.
May 7, 20263 min read
Texas Prepares to Launch Medical Psilocybin Program by End of 2026, Joining National Push for Psychedelic Therapy
Texas is developing a medical psilocybin program to treat depression, PTSD, and substance use disorders, with support from Trump's executive order and FDA fast-tracking.
May 7, 20265 min read